OTX015: Phase Ib started

Oncoethix S.A., Lausanne, Switzerland Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Product: OTX015, ZZZ-803 Business: Cancer Molecular target: Bromodomain containing 2 (BRD2); Bromodo...